Three-Vessel Versus Unilateral Antegrade Cerebral Perfusion in Emergency Total Arch Replacement for Acute Type A Aortic Dissection
MACP
A Retrospective Chart-Review Evaluating Direct Three-Vessel Antegrade Cerebral Perfusion Versus Unilateral Right Axillary Antegrade Cerebral Perfusion in Emergency Total Arch Replacement for Acute Type A Aortic Dissection at CMUH (2021-2025)
1 other identifier
observational
201
1 country
1
Brief Summary
This single-centre retrospective observational cohort study describes the technical feasibility of direct three-vessel antegrade cerebral perfusion, designated modified antegrade cerebral perfusion (MACP), during emergency total arch replacement for acute type A aortic dissection. MACP delivers antegrade cerebral perfusion directly to the brachiocephalic, left common carotid, and left subclavian arteries. Outcomes are summarised descriptively and compared exploratorily with unilateral right axillary antegrade cerebral perfusion (uACP). Because perfusion strategy and treating surgeon were completely confounded, the comparative analyses are intended only to contextualise the technical experience and generate hypotheses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 20, 2025
CompletedFirst Posted
Study publicly available on registry
June 29, 2025
CompletedJuly 1, 2026
June 1, 2026
4.3 years
June 20, 2025
June 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Stroke
Postoperative stroke during the index admission, defined as an abrupt focal neurological deficit due to cerebral infarction or intracranial haemorrhage confirmed on postoperative computed tomography or magnetic resonance imaging and adjudicated by a consultant neurologist.
During the index admission, up to hospital discharge.
Secondary Outcomes (10)
In-Hospital Mortality
During the index admission, up to hospital discharge.
Hospital Length of Stay
From surgery to hospital discharge.
ICU Length of Stay
From postoperative ICU admission to ICU discharge during the index admission.
Mechanical Ventilation Duration
During the index admission, up to liberation from invasive ventilation.
Postoperative Acute Kidney Injury (AKI)
Within 7 postoperative days.
- +5 more secondary outcomes
Study Arms (2)
Direct Three-Vessel ACP (MACP) Group
Patients undergoing emergency total arch replacement for acute type A aortic dissection in whom direct three-vessel antegrade cerebral perfusion was delivered to the brachiocephalic, left common carotid, and left subclavian arteries.
Unilateral Right Axillary ACP (uACP) Group
Patients undergoing emergency total arch replacement for acute type A aortic dissection in whom antegrade cerebral perfusion was delivered unilaterally through right axillary artery cannulation.
Interventions
Unilateral antegrade cerebral perfusion delivered through right axillary artery cannulation during emergency total arch replacement.
Direct antegrade cerebral perfusion through balloon-tipped catheters inserted into the brachiocephalic, left common carotid, and left subclavian arteries during emergency total arch replacement.
Eligibility Criteria
Consecutive adult patients who underwent emergency total arch replacement for acute type A aortic dissection at China Medical University Hospital, Taichung, Taiwan, between 1 January 2021 and 30 April 2025. The analytic population was restricted to patients who received either direct three-vessel antegrade cerebral perfusion (MACP) or unilateral right axillary antegrade cerebral perfusion (uACP).
You may qualify if:
- Adults aged 18 years or older.
- Patients who underwent emergency total arch replacement for acute type A aortic dissection at China Medical University Hospital between 1 January 2021 and 30 April 2025.
- Patients who received either direct three-vessel antegrade cerebral perfusion (MACP) or unilateral right axillary antegrade cerebral perfusion (uACP).
You may not qualify if:
- Incomplete key clinical, operative, or outcome data precluding analysis.
- Preoperative modified Rankin Scale score of 4 or higher.
- Ischemic stroke within 30 days before surgery.
- Remote prior stroke history or unavailable prior-stroke status.
- Patients managed with cerebral perfusion strategies other than MACP or uACP.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University Hospital
Taichung, 40447, Taiwan
Related Publications (1)
Pitts L, Kofler M, Montagner M, Heck R, Iske J, Buz S, Kurz SD, Starck C, Falk V, Kempfert J. Cerebral Protection Strategies and Stroke in Surgery for Acute Type A Aortic Dissection. J Clin Med. 2023 Mar 15;12(6):2271. doi: 10.3390/jcm12062271.
PMID: 36983272BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
En-Bo Wu, M.D.
Department of Anesthesiology, China Medical University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2025
First Posted
June 29, 2025
Study Start
January 1, 2021
Primary Completion
April 30, 2025
Study Completion
June 1, 2025
Last Updated
July 1, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly because the dataset was derived from retrospective electronic health records and contains potentially sensitive clinical information. Any external access, if considered, would require separate institutional review and ethics approval.